Executive summary

Continued clinical cancer care during the Covid-19 pandemic

Researchers at the Antwerp University Hospital published their findings of using RemeCare’s tele-monitoring solution to continue oncologic care during the pandemic in the British Journal of Oncology.

Read the summary

Leading hospitals use RemeCare

"Our consultations have become much more structured. By the time the patient arrives we have a full journal and know of any issues that they've had since the last visit."

Dr. Vincent Verschaeve
Oncologist responsible of the home care oncology program of the GHDC

"Thanks to RemeCare we can differentiate whether symptoms should lead to a hospital visit or not."

Prof. Dr. Marc Peeters
Head of department Oncology UZA

"RemeCare gives us a sense of security. We know if patients are therapy compliant and we can avoid emergencies or unexpected consultations."

Prof. Dr. Christof Vulsteke
Head of department Oncology AZ Maria Middelares

Maximizing return-on-care for clinical teams

RemeCare is already available for an array of different care pathways. Schedule a demo below and start embracing a return-on-care built on top of RemeCare today.

Schedule a demo